Status: Not yet recruiting
Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR
Prospective study is designed to evaluate the safety and efficacy of Myval THV series in patients with severe symptomatic non- or mild-calcified aortic regurgitation.
Participants needed: 164
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Ceric SàrlUpdated: Aug 7, 2026
Eligibility criteria
Patient above 18 years of age. [+7]
Patients who are not willing to provide informed consent form, or whose legal he... [+25]